Serina Therapeutics, Inc. Total Liabilities and Equity
Serina Therapeutics, Inc. (SER) had Total Liabilities and Equity of $25.81 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-13
- 2026-06-30: Liabilities and Equity $25.81M.
- 2026-03-31: Liabilities and Equity $27.30M.
- 2025-12-31: Liabilities and Equity $6.95M.
- 2025-09-30: Liabilities and Equity $12.41M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $25.81M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $27.30M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $6.95M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $12.41M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $8.94M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $6.73M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $6.72M 10-K · filed 2026-03-25 | |
| 2024-09-30 | $7.43M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $10.71M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $10.86M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $8.97M 10-K · filed 2025-03-24 | $11.96M 10-K · filed 2024-03-22 |
| 2023-09-30 | $12.21M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $12.28M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $12.53M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $3.24M 10-K · filed 2024-03-22 | |
| 2022-09-30 | $2.01M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $2.58M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $2.72M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.15M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $2.43M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.54M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $3.16M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $3.92M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $4.20M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $4.76M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $5.09M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $7.44M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $8.18M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $10.26M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $12.32M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $10.67M 10-K/A · filed 2020-03-31 | |
| 2017-12-31 | $9.63M 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |